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Työssä esitellään hydrogeelit materiaalina, joiden avulla sydänsoluja voitaisiin mahdol-
lisesti kasvattaa. Kirjallisuusosiossa käydään lyhyesti läpi myös sydämen rakenne, sy-
däninfarkti sekä menetelmä jolla infarktin aiheuttamaa sydänlihasvauriota on yritetty 
korjata.. Injektoitaessa pelkkiä sydänlihassoluja sydänlihakseen ne lähtevät pois paikal-
taan eivätkä uudista kudosta. Materiaali, joka auttaisi pitämään solut toimintakykyisinä, 
voisi löytyä hydrogeelien joukosta. Hydrogeelit ovat joukko verkottuneita hydrofiilisiä 
polymeerejä, joiden ominaisuuksia voidaan säädellä muun muassa silloittamisasteella. 
Hydrogeelin pitäisi muistuttaa mekaanisilta ominaisuuksiltaan soluväliainetta, jotta sy-
dänlihassolut menestyisivät sen sisällä tai pinnalla. Sekä liuosten että itse hydrogeelin 
olisi oltava myrkytön ja nopeasti geeliytyvä.    
 
Tutkimuksen tarkoituksena oli valmistaa injektoitava hydrogeeli. Hydrogeelin valmis-
tusaineiksi valikoituivat poly(N-isopropyyliakryyliamidi)n ja akryylihapon kopolymeeri 
(PNIPAM-co-AA) sekä luonnonpolymeerit hyaluroni ja alginaatti. PNIPAM on laajalti 
tutkittu biomateriaali, jota pidetään yleisesti sopivana lääketieteellisiin sovelluksiin. Se 
on myrkytön ja geeliytyy lämmön vaikutuksesta (30–32 ˚C) mikä mahdollistaa sen käy-
tön elimistössä hydrogeelin osana. Toisaalta NIPAM monomeeri on myrkyllinen ja 
PNIPAM ei ole biohajoava. Yhdistämällä (PNIPAM-co-AA) biohajoavaan polymeeriin 
voidaan kuitenkin saavuttaa osittainen biohajoavuus. Hyaluroni ja alginaatti ovat po-
lysakkarideja, joiden rengasrakenteeseen saadaan aldehyditoiminnallisuus perjodaatti-
hapetuksella. Muokattaessa PNIPAM-co-AA adipiinihapon dihydratsidilla di-imidin 
läsnä ollessa, saadaan karboksyyliryhmien tilalle dihydratsidiryhmät. Syntynyt PNI-
PAM-co-ADH, hyaluroni ja alginaatti analysoitiin NMR ja FTIR-spektroskopialla. Hy-
aluroni ja alginaatti hapetettiin perjodaatilla aldehydirakenteen saavuttamiseksi. Alde-
hydirakenteessa olevan karboksyylihapen sekä PNIPAM-co-ADH:n hydratsidiryhmien 
välille syntyy yhdistettäessä hydratsonisidos. Komponenteista tehtiin geelejä eri liuos-
konsentraatioilla ja lämpötiloissa. Pysyvin geeli valmistettiin yhdistämällä 60 mg/ml 
PNIPAM-co-ADH- ja alginaattiliuoksia suhteessa 1:1. Geelit olivat heikkorakenteisia 
koska 15 % silloittaminen ei ole riittävä pitämään geeliä koossa.  
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The literature review part of this thesis presents the basic structure of the heart and its 
properties from the tissue engineering perspective. Myocardial infarction is presented. 
The challenge is approached in context of the functionalized matrix or hydrogel. Hy-
drogels used in the treatment of myocardial infarction are presented in Appendices 1-5. 
  
In the practical part of this thesis, the aim of the study was to modify materials for mod-
ular semisynthetic injectable hydrogel. A commercial copolymer of poly(N-isopropyl 
acrylamide), PNIPAM, and acrylic acid was chosen to be the fundamental part of the 
gel. The copolymer consists of PNIPAM chains with 15 mol-% acrylic acid. The car-
boxylic acid residues of acrylic acid are replaced with dihydrazide functionality using 
carbodiimide crosslinker resulting in PNIPAM-co-ADH. Being thermo sensitive, non-
toxic and widely studied biomaterial, PNIPAM and its derivatives can act as starting 
materials for a wide variety of applications. On the other hand, the monomer is toxic 
and the polymer is not degradable. The polymer can be modified and combined chemi-
cally with biodegrading materials to make it partially degradable. In this study two natu-
ral polysaccharides, hyaluronic acid and alginate were chosen to be another component 
of the hydrogel. Hyaluronic acid is a polysaccharide found in the extracellular matrix, 
especially of soft connective tissues. Hyaluronic acid based hydrogels can be made stiff 
or soft; thus they offer a wide range of platforms for biomedical applications. Alginate 
is extracted from seaweed. Alginate hydrogels are versatile and well-studied biomateri-
als for various medical applications. They have been used as cell delivery vehicles and a 
support matrix for tissue engineering and as model extra cellular matrices for in vitro 
cell experiments.  
 
A sodium periodate oxidation procedure was used to attain aldehyde functionality. 
When these were combined with PNIPAM-co-ADH with different concentrations, some 
gelation was observable. The best combination was PNIPAM-co-ADH and partially 
oxidized alginate with 1:1 ratio. Other gels prepared were very weak, unstable and the 
degree of hysteresis was substantial. The unmodified and modified materials were char-
acterized with Fourier transform infrared spectroscopy (FTIR) and proton nuclear mag-
netic resonance (
1
H NMR). 15 % crosslinking is not enough to keep the gels together. 
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TERMS AND ABBREVIATIONS 
 
ADH   Adipic acid dihydrazide. 
 
Desmosome Specialized cell junction linking two cells by tying their outer cell 
membranes together with intermediate filaments. 
 
EDC N-(3-dimethylaminopropyl)-N’-ethyl carbodiimide. Crosslinker 
used in biotechnology. 
 
Gap junction Common in cardiac muscle, facilitates the cell-to-cell passage of 
small molecules.  
 
HA   Hyaluronic acid 
 
Intercalated disc Intercellular junction between individual cardiac muscle cells.  
 
LCST Low critical solution temperature. Temperature in which polymer 
solution undergoes phase transition.  
 
Myofibril The organelle of cardiac muscle cells which is a long cylindrical 
mass of contractile protein fibers (actin + myosin). Organized as 
a series of repeating sarcomeres. 
 
Myofilament  The structural unit of a myofibril. 
 
PNIPAM poly(N-isopropylacrylamide). Thermoreversible polymer used in 
e.g. biomedical applications. 
 
Sarcomere One of the segments into which a myofibril of striated muscle is 
divided. 
 
Syneresis The extraction or expulsion of a liquid from a gel. 
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1 INTRODUCTION 
Heart related problems are a widespread cause of human suffering. The economic im-
pacts are also significant when working-age people are not able to rehabilitate e.g. after 
myocardial infarction. The heart is not able to repair itself efficiently on a cellular level. 
(Anversa et al. 2006) This problem could be approached by delivering cell-life support-
ing material to the heart. Scaffolds have been prepared for this purpose. (You et al. 
2011) A surgical operation always presents a risk to the patient, particularly those who 
might be in a weak condition due to myocardial infarction. One alternative approach is 
an injectable hydrogel which could be delivered to the heart without invasive surgery, 
that is, through catheter. (Martens et al. 2009)  
 
In this thesis is presented the use of hydrogels in regenerative medicine concerning 
probably the most serious heart failure or myocardial infarction. In the traditional cell 
therapy, in which cells are injected in to the myocardium, the challenge lies in cell dis-
charge out from the myocardium. (Hofmann et al. 2005) A hydrogel could provide a 
safe environment for injected cells to remain and function together with individual’s 
own heart cells. The challenge is to find a gel suitable for this application. Hydrogel 
must possess relevant biological, mechanical, chemical and drug delivering properties 
so that it resembles myocardial tissue. This challenging task has been approached with 
synthetic and natural hydrogels. (Mihardja et al. 2008; Li et al. 2012) The solution 
might lie in combining synthetic and natural materials to attain desired properties. 
(Yoon et al. 2009) 
 
The goal of the practical part in this Master’s thesis was to modify materials for injecta-
ble hydrogel reproducing a study by Patenaude et al. (2012). Functionalized natural pol-
ysaccharides together with a copolymer consisting of poly (N-isopropyl acrylamide) and 
acrylic acid are combined without any stimulus (e.g. light or heat). Copolymer is modi-
fied through carbodiimide chemistry to introduce hydrazide functionality in the copol-
ymer chain. Hyaluronic acid and alginate gain their aldehyde functionality through oxi-
dation with sodium periodate. The materials are characterized with Fourier transform 
infrared spectroscopy (FTIR) and proton nuclear magnetic resonance (
1
H NMR). In the 
gel tests, the solutions are prepared with different concentrations and temperatures. 
These solutions were prepared to a gel either by using a pipette and a petri dish or two 
syringes integrated with an adapter. 
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2 HYDROGELS 
Hydrogels are polymeric network-like materials which have high water content and 
varying physical properties. They can be engineered to resemble body the extracellular 
environment of the tissue both mechanically and compositionally. Biocompatible hy-
drogels can be modified to support cell compatibility. It has also been shown that cells 
grow more naturally in 3-D environments like hydrogels. (Tibbitt et al. 2009; Seliktar 
2012) 
 
Hydrogels can be altered to a variety of physical forms, including slabs, microparticles, 
nanoparticles, coatings and films. Different forms of hydrogels are commonly used in 
clinical practice and experimental medicine for a wide range of applications, including 
tissue engineering and regenerative medicine, diagnostics, cellular immobilization, sep-
aration of biomolecules or cells and barrier materials to regulate biological adhesions. 
(Hoare et al. 2008; Tibbitt et al. 2009; Seliktar 2012) 
2.1 Hydrogel materials 
Hydrogel materials, their basic structure and derivatives, main source and applications 
in cardiac tissue engineering are presented. The division is done into synthetic and na-
ture originated materials. The hydrogels presented here are also in Appendix 1. 
2.1.1 Hydrogels of natural origin 
Polymers from natural origin have proofed their biocompatibility. Usually, they do not 
require much processing. These are the reasons they have been studied in the regenera-
tive medicine of the heart. (Nelson 2011) Most of the polymers are also easily accessi-
ble due to large number suppliers. For example Google gives 59 800 results for ‘medi-
cal grade alginate supply’ (19.3.2014). 
 
Uneven quality of the natural products represents a problem. Consistence can vary from 
batch to batch. Also, they do not possess compatible biomechanical properties; regener-
ative techniques relying on these hydrogels are about supporting cell delivery, not 
strengthening the heart tissue. (Wang et al. 2010.) Applying hydrogels consisting of 
natural originated polymers is challenging. Their properties (mechanical, degradation, 
gelation etc.) can be difficult to modify. (Tous et al. 2011.) Availability presents a prob-
lem too. 
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2.1.1.1 Matrigel™ 
Matrigel™ possesses a complicated structure; it is a mixture of proteins found in the 
extracellular matrix (ECM) that have been extracted from Englebreth-Holm-Swarm 
tumors in mice. Matrigel™ consists primarily of laminin, collagen IV, enactin and hep-
aran sulphate proteoglycan. It includes also growth factors including basic fibroblast 
growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 
(IGF-1), platelet-derived growth factor (PDGF), nerve growth factor (NGF), transform-
ing growth factor (TGF) and other growth factors which have not been fully identified 
chemically. The heterogeneous construction is thought to influence cell gene expres-
sion. (Ou et al. 2011.) 
 
One important application of Matrigel™ is for the growth of human embryonic stem 
cells. Matrigel™ is used to mimic the ECM in cancer and stem cell culture. It has been 
shown to be very convenient for culturing stem cells due to its ability to maintain self-
renewal and pluripotency. (Hughes et al. 2010.) 
 
Matrigel has been implanted alone and with neonatal cardiomyocytes to the mice model 
of myocardial infarction. (Zhang 2006) Gel stopped the progress of the infarction. When 
gel contained cells it helped to maintain heart wall thickness and regional contraction 
better. (Kofidis et al. 2004.) 
2.1.1.2 Silanized hydroxypropyl methylcellulose  
Hydroxypropyl methylcellulose (HPMC) is a commercially available hydrogel. The 
structure of the repeating unit is shown in Figure 2.1. 
 
 
 
 
 
 
 
 
 
Figure 2.1 Repeating structure of hydroxypropyl methylcellulose (HPMC) (sigmaaldrich.com). 
 
Mathieu et al. (2012) approached the challenges of infarcted cardiac tissue by seeding 
mesenchymal stem cells (MSC) in to it. HPMC was silanized (Si-HPMC) to support the 
proliferation and growth of MSC. MSC are proofed beneficial to infarcted cardiac tissue 
but are unable to survive without a supporting medium. MSC were injected in to the 
  4 
heart of rats with Si-HPMC gel. Results showed that intramyocardial injection of MSC 
gave a therapeutic benefit starting four weeks after myocardial infarction. It is not sure 
that these beneficial effects are related to the specific scaffolding properties of the Si-
HPMC hydrogel. (Mathieu et al. 2012.) 
2.1.1.3 Alginate -based hydrogels 
Alginate is composed of blocks of (1–4) β-d-mannuronic acid monomers (M) and 
blocks of α-l-glucuronic acid monomers (G) (Figure 2.2). Depending on the source and 
processing, molecular weight ranges between 10 and 1000 *10
3
 g/mol. (Baldwin et al. 
2009) The amount of each monomer and the sequential distribution of the monomer 
blocks along a polymer chain vary depending on the source of the alginate. Divalent 
cations such as Ca
2+
 bind blocks of G monomers along adjacent polymer chains, creat-
ing ionic interchain salt bridges which result in the gelation of the aqueous alginate so-
lutions. (Mihardja et al. 2008.)  
 
 
 
 
 
 
 
 
Figure 2.2 Repeating unit of alginate. 
 
Normally, cells have difficulties adhering to the alginate due to lack of binding sites. 
Mihardja et. al (2008) mixed alginate solution with conducting polymer polypyrrole. It 
was hypothesized that cells could adhere better in this compound due of its polycationic 
nature. Alginate-polypyrrole hydrogel was found to enhance arteriogenesis. The chal-
lenges lie in processing and modifying the mechanical properties of polypyrrole.  
 
Yu et al. (2009) prepared alginate gels from a 1.5 % alginate solution in 0.9 % NaCl. 
Alginate gel formation was based on the addition of the cross-linker solution (102 mM 
CaCl2). Their studies showed that intramyocardial injections of alginate can reshape a 
dilated left ventricle and improve ventricles function. It was demonstrated that the sur-
face modiﬁcation of polymers can inﬂuence the microenvironment of infracted myocar-
dium. 
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2.1.1.4 Chitosan -based hydrogels 
Chitosan is partially N-deacetylated chitin, and chitin is a linear homopolymer of 1, 4 -
linked N-acetyl-D-glucosamine (Figure 2.3). Chitosan has many useful biological prop-
erties when applied as a biological adhesive or wound dressing; biocompatibility, bio-
degradability, hemostatic activity and wound healing acceleration. (Fujita et al. 2004.) 
 
 
 
 
 
 
 
 
 
Figure 2.3 Repeating unit of chitosan. 
 
In their study Fujita et al. (2004) evaluated the fibroblast growth factor (FGF-2) incor-
porated chitosan hydrogel as a myocardial angiogenic therapy using a rabbit model of 
myocardial infraction. FGF-2 was added to the chitosan hydrogel and most FGF-2 mol-
ecules in the chitosan hydrogel remained biologically active. They were released from 
the chitosan hydrogel upon the in vivo biodegradation of the hydrogel. FGF-2-chitosan 
hydrogel showed effectiveness in angiogenesis. Disadvantages of using a polymer orig-
inated in nature must be taken on account. (Fujita 2004.) 
2.1.1.5 Fibrin -based hydrogels 
In a study by Martens et al. (2009) it was examined how controlling the composition of 
a fibrin-based hydrogel can be prepared so that it is compatible with available percuta-
neous injection catheters. Hydrogel composing of 2% of bovine fibrinogen could be 
delivered under desired conditions i.e. having ten minutes injection window. It en-
hanced the local retention of injected cells in the heart and prevented their redistribution 
to distance organs. System was found to be suitable for the delivery of all cell types. 
(Martens et al. 2009.) The structure of the fibrinogen is very complicated. It does not 
possess a structure suitable for drawing it on a molecular level. 
2.1.1.6 Hyaluronic acid  
Hyaluronic acid (HA), is ubiquitous, non-sulfated glycosaminoglycan, linear polysac-
charide of 2000–25000 repeating units of the disaccharide [–β (1, 4)-D-glucuronic acid-
β1, 3-N-acetyl-D-glucosamine]n (Figure 2.4). 
 
O
OH
NH2
O
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O
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NH2
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n
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 The molecular weight of HA is in the range (102–104) kDa and chains have length of 
2–25 μm. (Gaffney et al. 2009.) 
 
 
 
 
 
 
 
Figure 2.4 Repeating unit of hyaluronic acid. 
 
The hydrophilic and hydrodynamic properties of hyaluronic acid allow it to retain wa-
ter. The biological roles of hyaluronic acid are in part dependent on this property. HA 
forms loose, hydrated matrices with a pseudo-random coil configuration creating space 
to facilitate cell division. HA regulates cellular function through interaction with recep-
tors. Because of its size HA may interact with more than one cell and these interactions 
may have a role in tissue assembly (Gaffney et al. 2009.) The swelling properties of 
hydrogel vary with molecular weight of hyaluronic acid. (Yoon et al. 2009) 
 
Hyaluronic acid is easy to produce and modify, biodegradable and non-immunogenic 
extracellular matrix component that can be easily modified to display various chemis-
tries (Gaffney et al. 2009; Young et al. 2011.) 
 
Young et al. (2013) discovered that in myocardium, thiol-modified HA (HA-SH) (Fig-
ure 2.5) assembles and degrades over time.  
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Figure 2.5 Thiolated hyaluronic acid HA-SH (Young et al. 2013.) 
 
Improved cardiomyocyte maturation was observed. HA-SH-based hydrogels have lim-
ited biocompatibility probably due to interactions with free thiol groups. These materi-
als may be suitable for studying the effects of the dynamic mechanical clues of HA on 
cellular behavior. (Young et al. 2013.) 
 
Hyaluronic acid was functionalized by Tous et al. (2011) with hydroxyethyl methacry-
late (HeMA), to obtain a cross-linkable macromer (HeMA-HA) that cross-links similar 
to MeHA, and has additional ester bonds that provide further control over hydrogel deg-
radation (Figure 2.6). In the study two versions of MeHA hydrogels were compared 
(low and high mechanics) with the synthesized HeMA-HA hydrogels. (Tous et al. 2011) 
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Tous et al. (2011) compared hydrolytically degradable HA based hydrogels with stable 
HA hydrogels. These had similar mechanics and gel dispersion. 
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Figure 2.6 HeMA-HA synthesis and chemical structure (Tous 2011). 
 
When injected into infarct tissue in an ovine model, degradable hydrogels induced a 
stronger inflammatory response than stable ones. This may be associated with their deg-
radation. Hydrolytically degradable hydrogels revealed also that geometrical and re-
modeling changes are dependent on the mechanical and degradation properties of the 
hydrogel. No functional improvement was detected, but cardiac output (the volume of 
blood pumped by heart one minute) was better than in peer group. (Tous et. al 2011.) 
2.1.1.7 Collagen  
Collagen is the major protein of the extra cellular matrix. There are at least 12 types of 
collagen in various tissues. Types I, II, and III are the most abundant and form fibrils of 
similar structure. Type IV collagen forms a 2D reticulum and is a major component of 
the basal lamina. Collagen implants degrade through a sequential attack by lysosomal 
enzymes. It is widely used in tissue engineering applications. (Wang et al. 2010) 
 
Dai et al. (2005) injected collagen (composed of highly puriﬁed bovine dermal collagen 
(65 mg/ml) that consists of 95 % collagen I and 5 % collagen III) into myocardial in-
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farction on rats after one week from the damage. Collagen increased scar thickness 
which was studied six weeks later and did not induce an inﬂammatory response.  
2.1.2 Synthetic hydrogels 
In contrast to biological materials, synthetic materials allow for control over properties 
such as degradation, stiffness, pore size and gelation time. They either do not suffer 
from quality variability that occurs with materials originated from nature. (Rane 2011.) 
2.1.2.1 Acrylic acid -based hydrogels 
The hydrogel developed by Li et al. (2012) was based on N-isopropyl acrylamide 
(NIPAM), N-acryl oxysuccinimide (NAS), acrylic acid (AA) and a polymer based on N-
isopropyl acrylamide, N-acryl oxysuccinimide, acrylic acid and hydroxyethyl methacry-
late–poly(trimethylene carbonate) (HEMA-PTMC) (Figure 2.7). 
 
 
 
Figure 2.7 Synthesis and hydrolysis of copolymer by Li et al. (Li 2012). 
 
The hydrogel was thermo sensitive, injectable and the gelation time suitable for heart 
injection (6-7 s). Because of suitable gelation time, the hydrogel and the cells delivered 
were able to remain in the heart. The elastic modulus of hydrogel was varied and modu-
lus of 65 kPa was found to be the most suitable for cardiac cell differentiation. Mesen-
chymal stem cells delivered in the hydrogels differentiated into the cardiac lineage. (Li 
et. al 2012) 
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In 2009, Wang et al. prepared a series of hydrogels containing biodegradable dextran 
chain grafted with hydrophobic poly(ε-caprolactone)-2-hydroxylethyl methacrylate 
(PCL-HEMA) chain and thermoresponsive poly(N-isopropylacrylamide) (PNIPAM) 
chain was synthesized by the introduction of PCL (polycaprolactam)-grafted polysac-
charide chains into the PNIPAAm network. Four days after induction of myocardial 
infarction 200 cm
3
 of gel solutions were injected into four sites in the infarcted myocar-
dium. Each injection was 50 µl. The hydrogel solutions gelled immediately after injec-
tion. Results were investigated after four days. The intramyocardial injection of Dex-
PCL-HEMA/PNIPAM hydrogel may improve impaired cardiac function, enhance car-
diac contractility, decrease infarct size, and reduce cardiac remodelling in ischaemic 
myocardium. The hydrogel might also cause arrhythmia and have effects on diastolic 
function. 
 
Fujimoto et al. (2004) first prepared hydroxyethyl methacrylate-poly(trimethylene car-
bonate) (HEMA-polyTMC). It was synthesized by ring-opening polymerization of TMC 
initiated by HEMA with Sn(OCt)2 as a catalyst (Figure 2.9). Stoichiometric amounts of 
HEMA and TMC (molar ratio 1:2) were mixed in a ﬂask to which was added anhydrous 
toluene of equal mass to the TMC/HEMA mixture. Sn(OCt)2 in 1 cm
3
 toluene was add-
ed. The reaction was conducted at 120 ˚C for 1.5 h. The mixture was then dissolved in 
THF and precipitated in water. This precipitation process was repeated twice and the 
liquid precipitate was then isolated by centrifugation, dissolved in THF, and dried over 
anhydrous MgSO4. THF was removed by rotary evaporation. 
 
Then, poly (NIPAM-co-AA-co-HEMAPTMC) copolymers were synthesized by free 
radical polymerization. Monomers (NIPAM, AA, HEMAPTMC, Figure 2.8) were dis-
solved in 1,4-dioxane to form a 5 wt-% solution containing BPO (7.2 *10
-3
 mol/mol 
monomer). The polymerization was carried out at 70 ˚C for 24 h under argon atmos-
phere. The copolymer was precipitated in hexane and further puriﬁed by precipitation 
from THF into diethyl ether. The puriﬁed copolymer was vacuum dried. 
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Figure 2.8 Synthesis of HEMAPTMC and the copolymer poly(NIPAM-co-AA-co-HEMAPTMC). 
 
With ratio of (86/4/10; NIPAM/AA/HEMAPTMC) the hydrogel had suitable mechani-
cal properties, degraded in vitro in 20 weeks and was not cytotoxic. Injection of the hy-
drogel prevented ventricular dilatation and improved contractile function in a chronic 
rat infarction model. 
2.1.2.2 Polyethylene glycol -based hydrogels 
Polyethylene glycol (PEG) is a bioinert and stiff material (Figure 2.9). 
 
 
 
 
Figure 2.9 Repeating unit of polyethylene glycol. 
 
PEG based hydrogels gel within a few minutes at physiological temperature and pH, do 
not require the addition of initiators, produce no byproducts, have very low reactivity 
towards tissue and considered being biocompatible. The physical properties of the gels 
can be varied through the choice of molecular mass, functionality and crosslinker type. 
Carbohydrate and low molecular mass therapeutic agents may be coupled and released 
H
O
O
H
n
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from the gels, either with or without the degradation of the gel itself. Due to these prop-
erties it is thought to be suitable for cardiac applications. (Sanborn et al. 2002; Tirelli et 
al. 2002; Dobner et al. 2009) 
 
Dobner et al. derived PEG with vinyl sulfone so that it formed a degrading hydrogel. 
This hydrogel was able to support cell growth (primary human fibroblasts). (Lutolf et al. 
2003) Synthesized material slowed down the progress of MI and myocardial deteriora-
tion. (Dobner et al. 2009) 
 
Yoon et al. (2009) synthesized a hydrogel containing HA (MW 50 kDa) and PEG (Fig-
ure 2.10 and 2.11). 
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Figure 2.10 Two-step synthesis of acrylated HA (Yoon et al. 2009). 
It showed good results in myocardial regeneration after MI. Stem cells had showed dif-
ferential cellular behaviors, such as proliferation and differentiation.  
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This hydrogel was also trialed as a delivery system for growth factors and cells in bone 
regeneration in vivo. 
 
 
 
 
 
 
 
 
Figure 2.11 The final structure of the gel by Yoon et al. (2009). 
New bone tissue formation was observed in samples with stem cells. MI induced to rat 
myocardium was not disseminated in this study. (Yoon et. al 2009.) 
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3 HEART 
Heart is the organ responsible for bloodstream. Healthy heart of an adult human weighs 
approximately 250-350 g. It is located in the medial cavity if the thorax. The apex of the 
heart is pointing inferiorly and to the left. (Marieb et al. 2007.) Myocardial infarction is 
described due to its relevance to the cell death and need for repair. 
3.1 Structure 
The heart has four chambers – two atria and two ventricles. The right ventricle forms 
most of the anterior surface of the heart. Left ventricle forms the heart apex. The inter-
nal boundary between the left and right side of the heart is called interatrial septum. 
(Marieb et al. 2007.) 
 
The heart is enclosed in a double-walled sac called pericardium. Superficial part of this 
sac is the fibrous pericardium. Below is the serous pericardium which is a two –layered 
serous membrane. These are the coverings of the heart. The external part of the serous 
pericardium is called epicardium, which is part of the heart wall (Figure 3.1).  
 
    
 
Figure 3.1 Structure and layers of the heart tissue 
(http://www.texasheartinstitute.org). 
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With epicardium on top, the two others are myocardium in the middle and endocardium 
which is the inner wall of the heart (Marieb et al. 2007.) 
All of these layers are rich in blood supply. A groove on the surface of the heart is 
called the atrioventicular groove or coronary sulcus and it carries the blood vessels sup-
plying the myocardium. (Marieb et al. 2007.) 
3.1.1 Cardiac muscle cell 
The heart muscle, myocardium, is constructed of long cells attached to each other. 
These are called cardiomyocytes (Figure 3.2). One or two nuclei can be detected. Typi-
cally, the length of the cells is between 50 and 150 μm and breadth 10-20 μm. Cardiac 
myocytes are the contractile cells of the heart. There are differences between the myo-
cytes of the ventricles, the atria, and the conduction system. Atrial myocytes are long, 
thin and differ in some of the features from ventricular myocytes. (Marieb et al. 2007; 
Warrell et al. 2012) 
 
 
Figure 3.2 Cardiac cell (http://www.apsu.edu/). 
 
Myocardium is the bulk material of the heart. In myocardium layer the (Figure 2.1) 
branching cardiac muscle cells are in close connection by connective tissue fibers form-
ing a bundle. These bundles link all parts of the heart together. This network consisting 
of connective tissue, fibrous skeleton of the heart, reinforces the myocardium internally 
and anchors the cardiac muscle fibers. The thickness of this net, consisting of collagen 
and elastin, varies. (Heikkilä et al. 2000; Marieb et al. 2007; Klabunde 2011) 
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3.2 Myocardial infarction 
Myocardial infarction is a significant cause of morbidity and mortality worldwide. Of-
ten there are no symptoms of the disease until acute events or symptoms come out. It is 
a chain of processes including cell death, scar formation and ventricular dysfunction. 
These lead to the change of the cellular, structural and mechanical properties of the 
heart. (Nelson et al. 2011.)  
 
Infarction results in reduced cardiac function due to cardiomyocyte death, caused by 
prolonged ischemia and by reperfusion-induced injury. The damaged tissue is initially 
composed of a necrotic core surrounded by a border zone that can recover or become 
irreversibly damaged. The proliferative potential of the terminally differentiated cardi-
omyocytes is low meaning the heart is unable to repair itself. Collateral blood flow is an 
important determinant of infarct size and whether or not the border zone becomes irre-
versibly damaged. On the other hand, damage or defect in one of the four heart valves 
can ultimately lead to heart failure. (Schwinger et al. 1994; Peran et al. 2013)  
 
Infarcted tissue does not contribute to tension generation during systole, and therefore 
can alter ventricular systolic and diastolic function and disrupt electrical activity. Myo-
cardial infarction prevents the ability of the heart to change its force of contraction and 
therefore stroke volume in response to changes in venous return. Long-term conse-
quences include ventricular remodeling, ventricular failure, arrhythmias and sudden 
death. (Klabunde 2007) 
3.3 Properties of the heart 
Mechanical and electrical properties are discussed due to their relevance to the hydrogel 
applications. The hydrogel needs to be stiff enough to give appropriate response to the 
cardiac cells. The network of hydrogel being too stiff the cells are not able to exert 
themselves. This is also the case if the hydrogel is too weak. The hydrogel should allow 
the electrical impulses of the cardiac cells pass without interfering. 
3.3.1 Mechanical properties 
Between the cardiac cells, the intercellular spaces are filled with loose connective tissue 
matrix. This matrix is connected to aforementioned fibrous skeleton of the heart which 
links the cardiac cells together and reinforces the walls of the heart. This supportive 
structure acts as a tendon but also as an insertion providing the cardiac cells something 
to pull and exert against. (Marieb et al. 2007; Warrell 2012) 
 
The myofibrils are repeating units (sarcomeres) made up of thin actin filaments. Con-
traction results from sarcomere shortening produced by the ATP-dependent movement 
of the thin and thick filaments relative to one another. (Warrell 2012.) 
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Heart has a unique biomechanical behavior; it is strong but ductile in the systole phase 
and more elastomeric in the diastole phase. The Young modulus (E) which is used to 
define stiffness, is about 8-17 kPa for cardiac tissue. The mechanical measurements of 
fibrotic scars that develop after an acute myocardial infarction show that the fibrotic 
tissue is locally rigidified in comparison with normal tissue. Atomic force microscopy 
probing gives cell-scale elasticity values from 20 to 60 kPa for fibrotic wound. This 
means that cardiomyocytes behave poorly on a matrix stiffer than cardiac muscle. The 
Frank-Starling relationship describes the mechanical response of cardiac muscle during 
a full pump cycle. (Engler et al. 2006; Discher et al. 2009; Kraehenbuehl et al. 2008; 
van der Loo et al. 2008; Bhana et al. 2010.) 
3.3.2 Electrical properties 
There is an integrated electrical network inside the heart which directs the spontaneous 
heart cycle. It is continuous and conductive. Some cardiac cells have evolved to work in 
specialized roles, e.g. the myocytes that constitute the electrical conduction system. (Li 
et al. 2011.) 
 
The plasma membranes of adjacent cardiac cells interlock at specific junctions called 
intercalated discs (Figure 2.2). These discs contain links between cells, desmosomes, 
and gap junctions. The desmosomes prevent adjacent cardiac cells from separating dur-
ing contraction. Gap junctions allow ions to pass freely from cell to another, transmit-
ting the depolarizing current across the entire heart. Cardiac cells being electrically cou-
pled by the gap junctions, the whole myocardium behaves like a single coordinating 
unit. (Marieb et al. 2007.) 
 
There is a potential difference across the plasma membrane such that the inside of the 
cell is negative in comparison with the outside. The difference in Voltage is around 
80 mV. This is caused largely by the efflux of K+ from the cell through K+ channels and 
down its concentration gradient until the electronegative force retaining K
+
 in the cell 
balances the tendency for efflux. This is called cardiac action potential in cardiomyo-
cytes. (Klabunde 2011; Warrell 2012) 
 
The rhythm of the heart is determined by a pacemaker site called the sinoatrial node 
located on the posterior wall of the right atrium. The sinoatrial node consists of special-
ized cells that generate action potentials at a rate of 100-110 action potentials per mi-
nute. The sinus rhythm normally controls both atrial and ventricular rhythm. Action 
potential generated by the sinoatrial node spread throughout the atria, depolarizing this 
tissue and causing atrial contraction. The impulse then travels into the ventricles. Spe-
cialized conduction pathways within the ventricle rapidly conduct the wave of depolari-
zation throughout the ventricles to result in ventricular contraction. (Klabunde 2011; 
Warrell 2012) 
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In myocardial infarction (discussed later), declining conductivity of the heart cells is a 
part of the problem. (Mihardja et al. 2008) 
3.4 Cardiac tissue engineering  
In this chapter it is explained how myocardial infarction is treated with cell therapy. 
3.4.1 Delivering cells to the heart 
There is a growing need for stimulating heart cells and to regenerate lost heart tissue. 
One approach could be to deliver cells in to the heart. In theory, a human’s own cells 
could be differentiated into cardiac myocytes. Cells could be grown in vitro and injected 
back into the myocardial tissue of the donor (Figure 3.3). (Giraud et al. 2012) 
 
 
 
Figure 3.3 Cells collected from human are differentiated into cardiac myocytes in vitro. If cells 
are engineered further, even tissues and functionalized matrices like hydrogel for cells can be 
grafted to the heart (derived from Giraud et al. 2012).   
 
Hofmann et al. (2005) studied cells that were suspended in a buffer and injected into the 
heart. Unfortunately, the injected cells have failed to graft and die easily. One of the 
possible reasons is the hostile environment in the infarcted area. The blockage of the 
coronary artery causes very low oxygen and nutrient levels. Also, phagocytosis releases 
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apoptotic cytokines and cell toxic reactive oxygen species. These factors limit the sur-
vival of the delivered cells. In a study by Wang et al. (2010) it was shown that after two 
hours less than 10 % of the cells survived.  
 
The graft rate may be improved by regenerative cardiac tissue engineering, where cells 
are delivered with a supporting matrix like hydrogel. The supporting matrix prevents 
cell loss during the injection and provides an environment that protects the cardiac cells 
from the aforementioned hostile environment. It provides a mechanical support to ease 
the elevated heart wall stress caused by the loss of normal cardiac muscle cells. This can 
lead to cardiac function improvement. (Li et al. 2011.) 
 
In the study by Siepe et al. (2006) the myoblasts were injected to the heart tissue with 
and without biodegradable a polyurethane scaffold. Polyurethane scaffolds with my-
oblasts prevented post myocardial infarction progression toward heart failure as 
efﬁciently as direct intramyocardial injection.  
 
Giraud et al. (2008) prepared grafts containing myoblasts in a solution with rat tail col-
lagen and Matrigel™. In this study, the functionality of the heart recovered although it 
might not have been due to the treatment. All the myoblasts had disappeared from the 
heart after four weeks.  
 
In another study Giraud et al. (2010) prepared a highly porous scaffold from Artelon™ 
and polyurethane. Artelon™ is made of polyurethaneurea and a biomaterial which takes 
five years to hydrolyze completely. This scaffold was used as a matrix for myoblasts. 
The progression of myocardial infarction to a heart failure was prevented for up to six 
months after the injection of myoblasts. Graft implantation prevented heart failure up to 
nine months. The effect disappeared after 12 months when an absence of the transplant-
ed myoblasts within the scaffold was confirmed. 
3.4.2 Requirements for hydrogels in cardiac applications 
Any biomaterial mimicking the environment in the heart must have properties which 
resemble that of myocardial tissue. Hydrogels used in cardiac applications must have 
elastic modulus resembling that of myocardial tissue. It has been shown that myoblasts 
or cardiomyocytes differentiate and beat synchronously on a matrix with an intermedi-
ate elastic modulus of 8-11 kPa. (Engler et al. 2008.) 
 
Hydrogel stability or controlled degradation rate is an important factor when consider-
ing heart applications. Degradation products must have low toxicity meaning the com-
pounds formed can either be metabolized into harmless products or can be excreted by 
the renal filtration process. Hydrogels possess usually good biocompatibility. Their hy-
drophilic surface has low interfacial free energy in contact with body fluids, which re-
sults in a low tendency for proteins and cells to adhere to these surfaces. Also, the rub-
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bery nature of hydrogels minimizes irritation to surrounding tissue. (Smetana 1993; An-
derson 1994; Anderson et al. 1999) 
 
Application of the gel must be fitted according to gels theoretical gelation time. Martens 
et al. (2009) studied fibrinogen/ thrombin system which could be delivered to the heart 
by a catheter (Figure 3.1). If in situ polymerizing gel is used and applied too soon, the 
advantage of liquid-phase injection is lost. On the other hand, if application is done too 
slow or too late, catheter may be clogged. 
 
 
Figure 3.4 Catheter-based delivery of actively polymerizing compounds (Martens et al. 2009). 
 
Pore sizes should be of adequate size (>10 μm) to allow for cellular infiltration and mi-
gration in vivo. (Jawad et al. 2007) 
 
Overall, according to Shen ‘the ideal injectable material should be biodegradable, have 
a low immunogenity, be no cytotoxic, non-adhesive and have antithrombogenic proper-
ties, adequate mechanical properties, provide stiffness for the scar but at the same time 
being compliant with the heart beating and transmit properly the mechanical stimuli to 
the cells, induce angiogenesis or at least not disturb the angiogenic activity after incor-
poration, be capable of delivering cells and or bioactive molecules.’ (Shen et al. 2009.) 
 
3.4.3 Cells for testing the compatibility with the hydrogel 
Grown functional cardiomyocytes for microenvironment testing are almost impossible 
to achieve. Many different cells have been tested for differentiation including skeletal 
myoblasts and mesenchymal stem cells/marrow stromal cells, adult stem cells, embry-
onic stem cells, cardiac stem cells, umbilical cord blood cells and amniotic fluid stem 
cells. (Karam et al. 2012; Arnal-Pastor et al. 2013) 
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In Table 3.1 there are listed some cell types and details on using them in cardiac cell 
differentiation. 
 
Table 3.1 Possible cells for use in cardiac application development (derived from Giraud et al. 
2012). 
Cell type Main concern 
Side 
effects 
Mechanism of action 
Human 
embryonic 
stem cells 
Ethics, puriﬁcation Teratoma Diﬀerentiation /myogenesis 
Fetal/ neonatal 
cardiac muscle 
cells 
Ethics accessibility - Diﬀerentiation /myogenesis 
Induced 
pluripotent 
stem cells 
- Teratoma Diﬀerentiation /myogenesis 
Cardiac stem 
cells 
- - Diﬀerentiation /myogenesis 
Skeletal 
muscle my-
oblasts 
Poor 
electrocoupling 
Arrhythmia Paracrine eﬀect 
Bone marrow 
stem cells 
Puriﬁcation/ loss 
of function with 
age 
Arrhythmia Paracrine eﬀect 
 
Induced pluripotent stem cells (iPS) are derived from somatic cells (generally skin fibro-
blast) that have been transformed into pluripotent cells by the forced expression of stem 
cell-associated genes. They have the differentiation potential of embryonic stem cells, 
which allows them to be considered as possible candidates for regenerative cardiac tis-
sue applications. iPS cells have been differentiated into beating cardiomyocytes. They 
have quite good accessibility. Their application in clinical trials has been limited for the 
use of viral vectors that may promote malignancy and act as oncogenes. There is also a 
risk for teratomes because of their pluripotency. (Zhang et al. 2009; Forte et al. 2011; 
Giraud et al. 2012; Arnal-Pastor et al. 2013)  
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4 MATERIALS AND METHODS  
Choosing of a poly (N-isopropyl acrylamide) (PNIPAM) based material PNIPAM-co-
acrylic acid (PNIPAM-co-AA) was convenient due to materials suitable LCST (30-32 
˚C), biocompatibility, adjustable biodegrability and good reputation as a biomaterial. 
The most important property of PNIPAM is however its thermosensitivity. PNIPAM is 
hydrophilic at room temperature. When heated above a critical temperature, the 
PNIPAM polymer becomes relatively hydrophobic and the particles shrink. (Schmidt et 
al. 2010). This temperature is called the cloud point. 
 
PNIPAM (Figure 4.1) is used as a hydrogel in cell sheet engineering (Takahashi et al. 
2011; Patel et al. 2012). It is known that most cells adhere to hydrophobic surfaces. The 
cells attach to PNIPAM based substrates at 37 ˚C and are detached at 20 ˚C because of 
the structural alterations of the PNIPAM. These structural alterations delete the adhe-
sion between the cells and substrate. The junctions between cells are retained and a cell 
sheet is formed. (Takezawa et al. 1990) All cell types are not able to attach the PNIPAM 
substrate as such; they need anchoring molecules. (Chen et al. 2013) PNIPAM hydro-
gels are also used in drug delivery and as biosensors. (Guan et al. 2011) The hydrogel 
has been tried to adjust with multi-wall nanotubes and through copolymeration with a 
large number of other polymers. An example is a copolymer of PNIPAM and 2-
acrylamido-2-methylpropanesulfonic acid (AMPS) (Saikia et al. 2012; Chen et al. 2013) 
 
 
 
 
 
 
 Figure 4.1 The repeating structure of PNIPAM showing the polarity of different parts of 
PNIPAM unit. 
A study from 1997 reports that copolymer of PNIPAM and acrylic acid form gels with 
much desired properties: gels were translucent, experienced non-elastic deformation and 
there was no sign of hysteresis. (Han et al. 1998) PNIPAM-co-AA has been studied as 
an injectable drug delivery device and a drug delivering gel with cells. (Liu et al. 2006; 
Na et al. 2006)  
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Hyaluronic acid was chosen due to tissue regeneration properties, viscous properties, 
ability to retain water, biocompatibility and biodegradability (Yoon et al. 2009; Choh et 
al. 2011). Alginate was chosen due to biocompatibility and accessibility. Rapid gelation 
makes it suitable for cardiac tissue engineering. Hyaluronic acid and alginate are also 
relatively easy to modify into different derivatives possessing different properties. (Lee 
et al. 2012.) 
4.1 Materials 
Poly (N-isopropyl acrylamide)-co-acrylic acid (viscosity 7500―12500 cps in H2O, 
LCST (32-36) °C; information from the manufacturer), adipic acid dihydrazide (≥98 
%), 1-ethyl-3-(-3-dimethyl amino propyl) carbodiimide hydrochloride (EDC, commer-
cial grade, powder), sodium periodate (ACS reagent, ≥99.8 %), ethylene glycol (anhy-
drous, 99.8 %) and sucrose (≥99.5 %) were purchased from Sigma-Aldrich and used as 
arrived. Hyaluronic acid from Streptococcus equi (weight average molecular weight 
(1.5―1.8)*106 g/mol) and low viscosity alginic acid sodium salt from brown algae were 
also purchased from Sigma-Aldrich. 0.1 N HCl and 0.1 M NaOH were prepared in the 
Laboratory of Chemistry at Tampere University of Technology. 
4.2 Methods 
Procedures used in modification, characterization of materials and gel tests are de-
scribed. 
4.2.1 The modification of PNIPAM-co-AA with adipic acid dihydrazide 
using carbodiimide crosslinker  
PNIPAM-co-AA (shown in Figure 4.1.) must be stored and handled under inert atmos-
phere. These conditions were carried out with a glove box with an instrument nitrogen 
purge.  
 
 
 
 
 
 
Figure 4.2 Molecular structure of the constitutional repeating unit of the PNIPAM-co-AA. 
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The reaction (Figure 4.2) was done according to Patenaude et al. (2012).  
 
 
Figure 4.2 Crosslinking reaction of PNIPAM-co-AA (R
1
) and adipic acid dihydrazide (R
4
). 
Copolymer was weighed and flask was sealed with septum before it was taken out. 
Flask was connected to a nitrogen line. 100 cm
3
 of deionized water was added through 
syringe to gain 0.5 mass-% solution. Solution was left stirring overnight. After the dis-
solution of copolymer, 0.703 g of adipic acid dihydrazide (ADH) was added. A Mettler 
Toledo MI129 portable pH meter was tightly attached to one neck of the flask. 0.1 M 
HCl was added dropwise through a dropping funnel to attain the pH value of 4.75. 
Crosslinker 1-ethyl-3-(-3-dimethyl amino propyl) carbodiimide hydrochloride (EDC) 
was weighed (0.254 g) in the glove box. EDC was dissolved into 10 cm
3 
of deionized 
water. The EDC solution was added dropwise to the copolymer-ADH solution  
The pH value had to be controlled with HCl. The pH value was kept from 4.70 to 5.10 
during the overnight reaction. pH was raised to neutral next day by the addition of 0.1 
M NaOH. Two batches of PNIPAM-co-AA were crosslinked with EDC to adipic acid 
dihydrazide (Table 4.1).  
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Table 4.1 Amounts of reagents used in modifying of PNIPAM-co-AA. 
Batch 
PNIPAM-co-AA 
(g) 
EDC (g) ADH (g) 
KOPO-1 0.50104 0.25363 0.703 
KOPO-2 0.50231 2.79480 5.081 
 
 
EDC reacts with carboxylic acid groups to form an O-acylisourea intermediate that is 
displaced by nucleophilic attack from primary amino group NH2R
4
 (Figure 4.2). The 
primary amine forms an amide bond with the original carboxyl group and an EDC by-
product is released as a urea derivative. EDC crosslinking is the most efficient in acidic 
conditions. Modified copolymer PNIPAM-co-ADH (Figure 4.3, Picture 4.1) was dia-
lyzed in 12-14 kDa membrane for four days and lyophilized. 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 4.3 Molecular structure of the repeating unit of PNIPAM-co-ADH. 
The product was electric, pure white and had cotton wool like consistency (Picture 4.1). 
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            Picture 4.1 PNIPAM-co-ADH. 
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4.2.2 The oxidation of polysaccharides 
A known procedure, oxidation of polysaccharides to aldehydes, was used for hyaluronic 
acid and alginate. Sodium periodate was used as oxidizer. The reaction was carried out 
according to Ossipov et al. (2008). 
4.2.2.1 The periodate oxidation of hyaluronic acid  
500 mg of hyaluronic acid (HA) was put in to a three-necked flask and 100 cm
3
 of de-
ionized water was added (Picture 4.2). It was left to stir until HA was completely dis-
solved. This lasted usually circa 16 hours. 
 
 
Picture 4.2 Setup for oxidation of hyaluronic acid.  
 
Nitrogen flow was provided to the flask through a syringe. The nitrogen gas was vented 
through a needle in the septum. In the dark, a sodium periodate solution (2.7 cm
3
 H2O) 
was prepared and added into the HA solution with a syringe (Table 4.2). Sodium perio-
date is oxidizing, toxic and irritating so gloves and safety goggles must be worn.  
 
Table 4.2 Amount of reactants, reaction times and degrees of oxidation of two batches 
of hyaluronic acid oxidized with sodium periodate. 
 HA-1 HA-2 
HA (g) 0,501 0,502 
NaIO4 (g) 0,301 0,298 
Reaction time (h) 4 20 
Degree of oxidation (%) 7 25,9 
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Reaction was kept ongoing for a fixed number of hours as given in Table 4.1. Reaction 
(Figure 4.3) was stopped by adding 0.3 cm
3
 of ethylene glycol and allowed to react for 
one hour.  
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Figure 4.3 Sodium periodate oxidation of hyaluronic acid. 
 
The product (Figure 4.3) was purified by dialysis for three days with a 25 kDa mem-
brane. The membranes were rinsed with deionized water and the water was changed 
every day. 
 
 
 
 
 
 
 
Figure 4.4 The molecular structure of oxidized hyaluronic acid. 
 
Afterwards the product was lyophilized. Two batches of HA were oxidized.  
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The product had a cotton wool like consistency (Picture 4.3). It was very electric and 
difficult to handle. 
 
4.2.2.2 Periodate oxidation of alginate  
The overall procedure was similar to the oxidation of hyaluronic acid. The oxidizable 
structure in alginate (mannuronic acid) resembles that of glucuronic acid; hence the oxi-
dation reaction is similar to that of HA. (Ossipov 2008) Amounts of reagents are given 
in Table 4.3. 
 
 Table 4.3 Amount of reactants and reaction times of two batches of alginate 
oxidized with sodium periodate. 
 AL-1 AL-2 
Alginate (g) 0,5007 0,5000 
NaIO4 (g) 0,287 0,292 
Reaction time (h) 20 3 
 
Alginate was oxidized in two batches which varied with time. The periodate ion cleaves 
a bond forming the corresponding dialdehyde (Figure 4.5). Mannuronic acid is cleaved. 
 
 
 
 
 
 
 
 
 
Figure 4.5 The molecular structure of oxidized alginate. 
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Picture 4.3 Oxidized hyaluronic acid. 
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The state of the product was fluffy and white, similar to that of oxidized hyaluronic ac-
id. Oxidized alginate was very electric. It was also very difficult to handle.  
 
The oxidized hyaluronic acid, oxidized alginate and modified copolymer PNIPAM-co-
ADH are best to be stored in the refrigerator in a tightly sealed container. They should 
not be exposed to light. The humidity and light might affect their structure in an unfa-
vorable way. 
4.2.3 Characterization methods 
Reactants and products were characterized with different methods. The structures of 
alginate, oxidized alginate, hyaluronic acid and oxidized hyaluronic acid were con-
firmed with Nuclear Magnetic Resonance (NMR) spectroscopy and Fourier transform 
infrared spectroscopy (FT-IR). The spectra obtained were compared with those found in 
the literature. Copolymer and its derivatives were also studied with aforementioned 
methods. Obtained spectra were analyzed in the same extent as those of natural polysac-
charides that is to confirm their structures. The intrinsic viscosity of PNIPAM-co-AA 
and alginate were measured. 
 
Nuclear magnetic resonance spectroscopy (NMR) 
The nuclear magnetic resonance spectroscopy (NMR) is based on the energy states of 
magnetic atom nuclei. The behavior of nuclei in the magnetic field depends on the envi-
ronment of the nuclei and these dependences are seen in the spectrum of the nuclear 
magnetic resonance signal as a chemical shift of the resonance frequency. NMR is the 
only method that can be used to solve the structure of a dissolved molecule and its 
three-dimensional structure. NMR spectra are usually measured for samples in solution 
and it is a nondestructive method. (Larive 2012)  
 
In this study Varian Mercury 300 MHz NMR Spectrometer (Palo Alto, USA) was used 
to characterize all the reactants and products used. Aldehyde determination reactions 
were made only for oxidized hyaluronic acid. Samples were prepared on a previous day 
before measurement due to the poor solubility of materials. Spectroscopic grade D2O 
was used as a solvent. The concentration of the samples was 5 mg in 0.6 cm
3
. 
 
Fourier transform infrared spectroscopy (FTIR) 
The interaction of matter with infrared radiation is studied by Fourier transform infrared 
spectroscopy. With FTIR technique, a beam containing multiple frequencies of light is 
led through a sample. A sensor measures how much light is absorbed by the sample. 
Electromagnetic waves from 800 nm to 1 mm are used. This corresponds to (12 500–
10) cm
−1
 wave-number units which are usually used. Most stretching and bending fun-
damental vibrations of molecules occur in the mid-infrared region at 200–4000 cm−1. 
(McDowell 2014) 
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In this thesis, the FTIR spectra were measured with Perkin Elmer Spectrum One FT-IR 
Spectrometer (Waltham, MA, USA). The wave number employed was from 0 to 4000 
cm
-1
. (1-2) mg of the sample was weighed and mixed with 200 mg of KBr. KBr pellet 
was used as a background reference. 
 
Viscometry 
The intrinsic viscosity can be defined with Ubbelohde-type viscometer. A liquid is in-
troduced into the reservoir in the glass capillary. The sample is sucked through the ca-
pillary and measuring bulb. The liquid is allowed to travel back through the measuring 
bulb. The time is measured for the liquid to pass through two calibrated marks on the 
capillary. Viscosity can be obtained from these draining periods. These are repeated for 
parallel samples and pure solvent. (Harding 1997) 
 
Lauda PVS viscometer (Ubbelohde type, pipes 0C, capillary diameter 0.36 mm, Lauda-
Königshofen, Germany) was used in measuring the single-point intrinsic viscosities in 
the Biomaterials laboratory. The intrinsic viscosity of PNIPAM-co-AA was measured 
by dissolving the copolymer into water, chloroform and ethanol. For alginate, the vis-
cosity measurements were performed in water and in a 0.1 M NaCl solution. 
4.2.3.1 The number of aldehyde groups in oxidized hyaluronic  
acid 
To attain the exact number of aldehyde groups in oxidized hyaluronic acid (OxHA), an 
acetate buffer solution with pH 5.23 was prepared in the Biomaterials laboratory by 
mixing 79 cm
3
 0.2 M sodium acetate solution (prepared according to Lange’s Handbook 
of Chemistry and Physics from Sigma-Aldrich’s ≥99 % powder form sodium acetate) 
and 21.0 cm
3
 of 0.2 M acetic acid (Sigma-Aldrich, ≥99.7 %). OxHA (20 mg) and 2 cm3 
of buffer solution were mixed. Tert-butyl carbazate (0.0348 g) and 1 cm
3
 of buffer solu-
tion were gently mixed in a small glass bottle. Two aforementioned solutions and 1 cm
3
 
of buffer solution in a glass bottle were evacuated and put in to the glove box with ni-
trogen atmosphere. 
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Buffer solution (1 cm
3
) and NABH3CN (0.0166 g) were mixed in the glove box and 
added to OxHA after one hour. The reaction was left to stir for 24 h (Figure 4.5). 
 
 
Figure 4.5 The reaction between oxidized hyaluronic acid and tert-butyl carbazate. 
 
OxHA solution was precipitated three times with surplus acetone (Sigma-Aldrich, ≥99 
%). Finally, the precipitate was dissolved in 10 cm
3
 of deionized water. The product 
was dialyzed with 25 kDa membrane; 24 h in 0.1 M NaCl (Sigma-Aldrich, ≥99 %) and 
three days in deionized water. The sample was lyophilized. The dry product was sub-
jected to 
1
H NMR examination. The degree of oxidation (aldehyde content) was calcu-
lated by integrating the peaks using software (ACD NMR Processor) and comparing the 
signals around 1.4 ppm (9H, carbazate t-Boc) and 1.9 ppm (3H, oxHA acetamide) 
(Equation 1). (Jia 2004.) 
 
                                        (
      
         
)                                                 (1) 
 
The integrated areas are shown in NMR spectrum of HA-1 (Appendix 10). Results are 
presented previously in Table 4.2.  
4.2.4 Gelling 
In gel tests, the components were treated modularly. This means that the components 
were simply mixed together without any extra stimulus i.e. light or heat.  
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The components were mixed with a pipette in a cut plastic syringe or with two syringes 
integrated with an adapter (Picture 4.4). 
 
 
Picture 4.4 Two syringes integrated with an adapter. 
 
Two gelation tests were made with the copolymer from the first reaction, KOPO-1 (Ta-
ble 4.1). A 10 % solution of sucrose was prepared. Polymer and polysaccharides were 
dissolved to a sucrose solution and stirred overnight. Gels were prepared the next day 
with sample sizes of 0.2 cm
3
. 0.1 cm
3
 of copolymer and 0.1 cm
3
 of oxidized hyaluronic 
acid were pipetted to a 1 cm
3
 syringe which had the tip cut off. The solutions were rap-
idly stirred with a pipette tip. The gelation was observed in four time points: zero, one, 
five and 60 minutes. After 60 minutes, the syringe was emptied to a petri dish or opaque 
vial. 
 
The procedure was repeated with sample size of 0.6 cm
3
 to improve the observation of 
the progress of gelling. The solutions were heated in water bath to 37˚ C to observe the 
effect of the elevated temperature.  
 
Four gelation tests were made with KOPO-2. The procedure was similar with KOPO-1 
tests except the tests were carried out in room temperature. The solutions were prepared 
from distilled water instead of sucrose solution. Polyacrylamide based materials gel in 
sucrose solution if they gel in water. In the last two gelation tests, the KOPO-2 solutions 
were kept in 4˚ C to try out differences in solubility and manageability in comparison 
with room temperature.  
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5 RESULTS 
Results from characterizations are presented. All NMR spectra except those of 
PNIPAM-co-AA and its derivatives are available in Appendices 3, 4 and 5.  
5.1 NMR measurements 
5.1.1 PNIPAM-co-AA and PNIPAM-co-ADH 
Chemical shifts (δ) at 3.91 and 3.67 ppm peaks respond to the ―CH and ―CH2 groups. 
―CH and ―CH2 peaks are at 2.02 and 1.59 ppm (PNIPAM-co-AA). ―CH3 gives a 
peak at 1.15 ppm. H2O peak is at 4.75 ppm. PNIPAM-co-AA and PNIPAM-co-ADH 
spectra are presented in Figure 5.1. 
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Figure 5.1 PNIPAM-co-AA (grey), KOPO-1 (blue) and KOPO-2 (green). 
 
The amino group proton and the carboxylic proton are overlapped by the resonance of 
the deuterated water. (Larsson et al. 2001) The chemical shifts (δ) are given in Table 
5.1.  
According to Tzoc-Torre (2011), 0.5 ppm -1.2 ppm peaks are from the methyl groups 
from NIPAM, 1.2 ppm-1.8 ppm peaks are from the methylene groups (―CH2) from 
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NIPAM and AA, 1.8 ppm -2.5 ppm peaks are from the methinyl groups (>CH―) from 
NIPAM and AA. (Tzoc-Torre 2011) 
 
Table 5.1 Chemical shifts and corresponding protons in PNIPAM-co-AA, KOPO-1  
and KOPO-2. 
 
 
δ (ppm) (1) 
(CH3)2 ―CH2― 
―(CH2)4 ― 
(ADH) 
―CH― 
―NH2 
(ADH) 
―NCH2 >CH― 
1.1 1.5 - 1.9 - - 3.8 
PNIPAM-
co-AA 
1.16 1.59 (1.73) 2.02 - - 3.91 
KOPO-1 1.15 1.64 - 1.91 2.25 2.89 3.91 
KOPO-2 1.15 1.65 1.73 2.04 2.26 2.90 3.91 
(1) Larsson et al. 2001 
5.1.2 Hyaluronic acid 
The chemical shifts (δ) of hyaluronic acid and its derivatives are presented in Table 5.2. 
The NMR analysis of the oxidized products showed signals close to 3.60 ppm, which 
correspond to the hemiacetal formation of the aldehyde function. 
 
Table 5.2 Chemical shifts and corresponding protons in hyaluronic acid and its derivatives. 
 
 
 
 
 
 
 δ (ppm) (1,2)  
t-Boc ―NCOCH3 
―O―CH―C 
  │ 
  C 
 
―CH2OH― 
 
C―CH―O 
│ 
O 
- 2.07 3.51 -3.62 4.61 
Hyaluronic acid - 2.03 3.52 
4.62; 4.69; 
4.74 
HA-1 1.25 -1.45 2.03 3.35 -3.84 4.46 -4.89 
HA-2 1.25 -1.45 2.03 2.98 -4.89 4.22 -4.89 
(1) Bodnar et al. (2009) 
(2) Martinez-Sanz (2011) 
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5.1.3 Alginate 
The chemical shifts (δ) are presented in Table 5.3.   
 
Table 5.3 Chemical shifts and corresponding protons in alginate and its derivatives. 
 
δ (ppm) (1,2,3)  
Glucuronic acid Mannuronic acid 
3.42-3.71; 3.81; 5.37 3.78; 3.82-4.18  
Alginate 3.76-4.19 4.46-5.01 
AL-1 3.67-4.46 4.74-5.27 
AL-2 3.77-4.38 4.73-5.19 
(1) Cocco et al. 2003 
(2) Davis et al. 2003 
(3) Gomez et al. 2007 
5.2 FTIR measurements 
All Fourier transform IR spectra except those of PNIPAM-co-AA and its derivatives are 
presented in Appendix 6. 
5.2.1 PNIPAM-co-AA 
The FTIR data is given in table 5.4. The characteristic doublet of PNIPAM-co-AA at 
1368 cm
−1
 and 1387 cm
−1
 were evidence of the presence of isopropyl groups 
―CH(CH3)2) stretching.  
 
Table 5.4 FTIR data on PNIPAM-co-AA, KOPO-1 and KOPO-2. 
 
Group 
 
C(CH3)2 
(υ) 
C(CH3)2 
(υ) 
CH 
 (δ) 
―COO 
(υ)  
 (2) 
―C=O  
(υ) 
CH3  
(υ) 
N―H  
(υ) 
cm
-1 
 (1) 
1366 1387 1460 1569 1648 2877 3292 
PNIPAM-
co-AA 
1368 1387 1458 1539 1641 2878 3433 
Group 
N―H  
(γ) 
- 
―C=O  
(υ) 
N―H  
(υ) 
―NH―NH2 
        │ 
 
      (υ) 
KOPO-1 655-682 1700 
2935-
3073 
3434 
KOPO-2 663-673 1703 
2935-
3071 
3435 
(1) Chen et al. 2013 
(2) Mori et al. 2006 
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The peaks at 1458 cm
−1
 and 2973 cm
−1
 resulted from the bending of (CH) and methyl 
(―CH3) groups stretching of ―CH(CH3)2, respectively. 1641 cm
−1
 band represents 
amide I (―C=O stretching) band of NIPAM moiety. (Chen et al. 2013) Deprotonated 
―COO- group appears at 1539 cm-1 (Figure 5.2) (Mori et al. 2006) 
 
 
 
Figure 5.2 FTIR spectra of PNIPAM-co-AA, KOPO-1 and KOPO-2. 
5.2.2 Hyaluronic acid 
Infrared spectroscopy showed presence of ―OH stretch of COOH group at 3432 cm-1, 
―CH stretch at 2923 cm-1, COO― stretch at 1636 cm-1, ―NH stretch at 1548 cm-1 and 
C―O ether at 1052 cm-1. (Yue 2012)   
 
Table 5.5 FTIR data on hyaluronic acid, HA-1 and HA-2. 
 
Group 
 
C―OH 
(υ) 
―NH 
(υ) 
C=O 
(planar) 
(υ) 
C=O 
(υ) 
―CH 
(υ) 
―OH 
―NH 
(υ) 
cm
-1
 (1) 1043 1563 1617 - 2916 3412 
Hyaluronic 
acid 
1052 1548 1636 - 2923 3432 
HA-1 ~1050 ~1550 ~1600 1722 ~2900 ~3400 
HA-2 ~1050 ~1550 ~1600 1733 ~2900 ~3400 
(1) Yue et al. 2012 
 
In the spectra of oxidized hyaluronic acid batches the characteristic aldehyde shoulder 
was at 1722 and 1733 cm
-1
. Carboxyl peak had shifted to 3398 cm
-1 
and carbonyl peak 
to 1613 and 1618 cm
-1
.  
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5.2.3 Alginate 
The IR spectrum had characteristic absorption bands for hydroxyl groups at 3435 cm
-1
 
(stretch), carboxylate at 1419 cm
-1
 and carboxyl at 1629 cm 
-1
. (Nagpal 2013) The bands 
at 1316 cm
−1 
(C–O stretching), 1130 cm− 1 (C–C stretching), 1099 cm− 1 (C–O stretch-
ing), 1035 cm
− 1
 (C–O–C stretching), and 947 cm− 1 (C–O stretching) are indicators of 
saccharide structure. (Sartori 1997)  
 
Table 5.6 
 
Group 
 
C―O 
(υ) 
C―O 
(υ) 
C―C 
(υ) 
COOH 
(υ) 
COO
- 
(υ, ring) 
C=O 
(υ) 
―CH 
(υ) 
OH 
(υ) 
cm
-1
 (1) 947 1035  1416 1616 - 2929 3421 
Alginate 947 1099 1130 1419 1629 - 2928 3435 
AL-1 - - - - 1616 1733 - - 
AL-2 - - - - 1616 1730 - - 
 
In the spectra of oxidized alginate batches the characteristic aldehyde shoulder was at 
1733 and 1730 cm
− 1
. The asymmetrical stretch of carboxyl group peak at 1629 cm
− 1
 
had shifted to 1616 in both spectra.  
5.3 Gelling 
PNIPAM: AL-2 gel with 1:1 ratio and solutions with concentration of 60 mg/cm
3
 re-
sulted in slightly beige and opaque gel with liquid (Picture 5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Picture 5.1 Hysteresis in hydrazone linked PNIPAM: AL-2 gel with 1:1 ratio. 
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From all the ratios and concentrations tested, the syneresis was the slowest with 1:1 
ratio. Gel test results are presented in Appendix 2. Other combinations appeared not to 
produce a stable gel. Hysteresis increased with time. Gels came apart when they were 
gently rubbed between fingers. 
5.4 Viscosity measurements 
The intrinsic viscosity of PNIPAM-co-AA was measured by dissolving the copolymer 
into ethanol. It was also tried to dissolve it to water. In the specification sheet provided 
by the manufacturer the viscosity value was given in water. It was dissolved in ethanol. 
The results from measurements with ethanol varied too much to attain a reliable result. 
For PNIPAM-co-AA in ethanol (25 ˚C) the measured viscosity values range from 0.37 
dm
3
/g to 0.72 dm
3
/g. The draining periods varied from 637 to 914 s. Tubes in the vis-
cometer of Biomaterials Laboratory are not suitable for such long draining periods.  
 
For alginate in water (25 ˚C) the three attained intrinsic viscosity values are 0.913, 
0.954 and 0.994 dm
3
/g. For alginate in 0.1 M NaCl the intrinsic viscosity values were 
3.51, 3.68 and 4.09 dm
3
/g. With these results and using Mark-Houwink (α = 1.13,            
K = 6.9*10
−4
 cm
3
/g at 25
˚ 
C) constants of Martinsen et al. (1991), alginate molar mass 
was roughly estimated to be 120 000 mol g
-1 
(mean value). Zhong et al. (2010) used a 
0.40 m diameter Ubbelohde tubes.  
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6 DISCUSSION 
6.1 PNIPAM-co-AA 
The synthetic poly (N-isopropyl acrylamide), PNIPAM, has been studied as an injecta-
ble hydrogel for medical applications. It has many advantages, e.g. homopolymer has a 
convenient lower critical solution temperature close to the body temperature (30-32) ˚C. 
For injectable hydrogels, there are a few important basic requirements. It has to have a 
low or moderate viscosity and gel within a reasonable time window. It has to maintain a 
desired volume and have contact through an interface with tissue after gelation. When 
aiming for commercial application, a long shelf life and sterilization are essential. 
(Schmidt et al.2010; Byeongmoon et al. 2012; Ekenseair et al. 2012) 
 
PNIPAM is not biodegradable. It needs to be copolymerized in order to make it partially 
degrade. The reaction between aldehyde modified polysaccharides and hydrazides is 
very fast and the resulting hydrazone bonds will be labile to hydrolysis, which leads to 
gels that degrade in aqueous media. (Lee et al. 2000) 
 
Copolymer PNIPAM-co-AA was modified with adipic acid dihydrazide (ADH) to attain 
hydrazide functionality to the copolymer chain. N’-ethyl-N-(3-dimethylaminopropyl)-
carbodiimide (EDC) was used as a crosslinker. When modified copolymer solutions 
were heated they became turbid. This is due to the swelling of the copolymer which is 
characteristic of PNIPAM based materials. As the temperature is raised to cloud tem-
perature, PNIPAM chains collapse. Collapsed chains aggregate and solution turn turbid. 
In the gels prepared within this thesis, the syneresis was the topmost phenomenon. 
There was a considerable portion of the liquid phase in gels. When gels were prepared 
from solutions at 0˚ C, the portion of the gel was larger. Syneresis seems to be extensive 
in gels prepared from heated solutions. This might be due to the inhibition of molecular 
movement in a collapsed state of the polymer coils. (Chang et al. 1997) 
 
PNIPAM based gels often undergo syneresis which means shrinking and separation 
from solvent. This phenomenon can lead to high burst release especially in the case of 
hydrophilic drugs. Also the monomer is harmful though the polymer is not. There is 
also always risk for monomer residues to remain in the polymer or to appear over time 
with disintegration. (Overstreet et al. 2012) The commercial copolymer had 15 mol-% 
of carboxylic acid groups. It is impossible to convert all carboxyl functional groups into 
dihydrazide functionality. Even if all these groups could have been modified, the 
amount of crosslinks between copolymer and polysaccharide would have been inade-
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quate. This might be one reason for the weakness of the gel structure. Also, the solution 
with 60 mg/ml concentration might be too thick for sterilization. 
 
In the characterization of PNIPAM-co-AA has to be taken in account its hygroscopic 
nature. When dissolved in water, the carboxylic groups might deprotonate. This can be 
observable e.g. in FTIR spectroscopy signals. 
6.2 Hyaluronic acid and alginate 
Periodate oxidation is a recognized method for gaining flexibility in polysaccharides. It 
has limitations e.g. an oxidation limit of about 44 % occurs in alginates due to intramo-
lecular hemiacetal formation. (Painter 1973) The hyaluronic acid and alginate solutions 
were quite easy to prepare and handle. There is a vast amount of knowledge about these 
materials and the oxidation procedure is well established. The aldehyde structure is sen-
sitive to air and moisture. The unwanted change into acidic structure can be voided 
through proper storing conditions. In this study, the materials were kept in an incubator 
in the refrigerator. The materials were used almost immediately so there should not be 
any changes in the structure. 
 
NMR and FTIR measurements confirm successful oxidation modifications in alginate 
and hyaluronic acid. It was verified that hyaluronic acid had oxidized according to a 
well-known procedure with sodium periodate. Periodate treatment oxidizes the proximal 
hydroxyl groups to aldehydes opening the sugar ring to form a linear chain. While peri-
odate oxidation allows for the formation of a large number of functional groups, the 
disadvantage is the loss of the backbone structure. In the literature it is mentioned that 
this modification procedure is not favorable for cells. (Bulpitt 1999)  
6.3 The gels 
In this thesis it is presumed that all 15 % of the carboxylic acid groups in the PNIPAM-
co-AA had been replaced with dihydrazide groups. The number of dihydrazide groups 
remains unknown. Even if all of the carboxylic groups had been altered, the 15 % is still 
not enough the keep the gels together. The degree of crosslinking has effects on e.g. 
hydrogel swelling. (Krušić et al. 2006) 
 
The dilute PNIPAM-co-ADH solutions were much easier to handle when they were first 
kept in the refrigerator. Keeping them cool hinders the movement of the molecules in 
the water. Unfortunately dilute PNIPAM-co-ADH solutions did not form any gels with 
oxidized hyaluronic acid and alginate. The sterilization of dilute, flowing solutions is 
not a problem. In richer solutions e.g. 60 mg/cm
3
 concentration of the polymer, the solu-
tion cannot be called liquid-like. It reminded more of a gel and it was difficult to try to 
mix the components. One possible option could be to prepare thick PNIPAM-co-ADH 
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gel first and stir it continuously. Then the other components could be added in with a 
needle. The problem of injectability would remain. The stiffness of the gel can be modi-
fied with the molar mass of the PNIPAM. 
6.4 The characterization 
The data on the copolymer material is inadequate. The molar mass of the copolymer 
would have been important to know. In this work the amounts of reagents are almost 
educated guesses due to lack of information on PNIPAM-co-AA. With NMR and FT-IR 
methods it was only confirmed that there had been a change in the molecular structure. 
For polymers, the FTI-R is in general an informative method. With size exclusion 
chromatography there might have been a possibility to clarify the molar mass of 
PNIPAM-co-AA. 
 
The viscosity measurements made with Ubbelohde equipment do not seem reliable. The 
deviation in the results is too large. The reason for this might be the relatively bad solu-
bility of PNIPAM-co-AA in ethanol and alginate in water. Materials may sediment in 
the tubes of the viscometer. (Dan et al. 2010) The equipment used in the Biomaterials 
Laboratory was not suitable for these materials. 
 
For hyaluronic acid the NMR and FT-IR were relatively good methods. There is also 
good amount of references in the literature so the authentication of the material and 
changes in the structure were quite straightforward. The NMR spectrum of alginate was 
measured dissolving dried alginate in D2O. Another solvent might have been better for 
this purpose. The alginate peaks are very close to the solvent peak and they get inter-
fered. It is possible to attain more detailed information on alginate structure with NMR 
through performing acid hydrolysis. This pre-treatment depolymerizes the alginate and 
reduces the solution viscosity. The sequence of monomer residues notably influences 
the chemical shifts. This specification was not sensible for this thesis. (Cocco et al. 
2003; Davis et al. 2003; Gomez et al. 2007) In the research of alginate with FT-IR it 
would be interesting to know the ratio between the mannuronic and glucuronic acid. It 
has an effect on the band intensity. (Sartori et al. 1997) Alginate is a very well-known 
material so good references could be found. The seaweed extract is still under investiga-
tion and new data is being analyzed. 
6.5 General 
The gels prepared in this study were not stable enough to be exposed to further charac-
terizations. Pressure test, rheological measurements, swelling tests and cell tests are 
examples of what could be studied. As mentioned earlier, PNIPAM and its derivatives 
are being studied for cell culturing applications (Yongqing et al. 2013). Currently, it has 
to be doped with different cell anchoring substances. There is a need in tissue engineer-
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ing for a substrate to grow cell monolayers on and without extra additives. It should be a 
bulk product and have good usability. In this sense, an in situ prepared hydrogel for 
cells to grow, which properties were modifiable for a desired cell type, would present an 
ideal product. 
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7 CONCLUSIONS 
The goal in this study was to find a biocompatible, cell life supporting and injectable 
hydrogel with suitable mechanical properties. It was proven to be a challenging task. 
PNIPAM-co-AA was functionalized with dihydrazide (PNIPAM-co-ADH) using a car-
bodiimide crosslinker. Hyaluronic acid and alginate were oxidized with different 
amounts of sodium periodate to gain aldehyde functionality. Hyaluronic acid and algi-
nate with aldehyde functional groups were mixed with PNIPAM-co-ADH to with create 
in situ gelling hydrazine crosslinked hydrogels. The gels were prepared with different 
component ratios, different temperatures and methods. Gels prepared were not stable 
enough to execute further testing. PNIPAM-alginate gel prepared from 4 °C solutions 
with 1:1 ratio was the most stable combination. Even the most stable gel did not KES-
TÄÄ handling and fell apart in an hour.  
 
In the future, it would be sensible to prepare the copolymer in the laboratory instead of 
purchasing it. Basic polymerization equipment is relatively inexpensive. Through regu-
lation of the amounts of reagents it is possible to prepare a copolymer with a desired 
amount of modifiable groups. This way the knowledge of the material is better from the 
start. To the copolymer it might have been good to execute size exclusion chromatog-
raphy to clarify the molar mass. When the molar mass is known, it makes a whole new 
set of analysis methods possible. Also, the alginate should be characterized properly. 
The differences in structures between different types of alginates seem trivial, but the 
influence of the structure over gelation properties is considerable. There are established 
methods for defining detailed structure of alginate. The employed modular way in this 
thesis to make hydrogels is ideal for a medical hydrogel application. The components 
remain unreactive until they are combined in a sterile environment such as hospitals. 
Storing the components in a right manner is crucial. The functionality of the materials 
should be checked regularly. The PNIPAM-co-ADH solutions were very viscous. In-
stead of trying to pipette them a mold could be developed. Then the PNIPAM-co-ADH 
gel could be kept in movement with the mold and the other component could be added 
to it to get an even two-component gel. Thus, the concept of injectability should be re-
checked.  
 
In this study, the oxidation reactions were quite straightforward to execute. I have 
gained good hands-on experience from TUT laboratory courses and they became in use 
in this work. It was also very satisfying to notice that my article reading skills got a lot 
better. I learned to concentrate on what is relevant.  
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APPENDIX 1. HYDROGELS STUDIED FOR TREATMENT OF MYOCARDIAL INFARCTION 
Hydrogel 
Injection 
after 
myocardial 
infarction 
(MI) 
Gelation 
mechanism 
and time 
Stability 
Cells used in 
compatibility 
testing 
Mechanical  
properties 
Advantages Disadvantages 
Natural origin 
Alginate-polypyrrole 
 (Mihardja et al. 2008) 
One week Ionic - 
Human  
umbilical vein  
endothelial cells 
Best stiff-
ness for 
cells with 
0.025%  
concentra-
tion of 
polypyrrole  
Enhanced cell  
attachment,  
filtration,  
proliferation and 
angiogenesis 
Quality of alginate, 
changes in  
polypyrrole  
conductivity, 
 difficulties modifying 
polypyrrole 
Arginine-Glycine-Aspartic acid 
(RGD) modified alginate+  
alginate 
(Yu et al. 2009) 
Five 
weeks 
Ionic - 
Human  
umbilical vein  
endothelial cells 
Best cell 
growth with 
alginates 
over 50% of 
mannuronic 
acid 
RGD-modified  
alginate 
 enhanced  
angiogenesis more 
than  
alginate 
Uneven  
quality of  
alginate 
Chitosan+ fibroblast growth fac-
tor  
(Fujita et al. 2004) 
Immediate 
UV induced; 
30 s 
After four 
weeks  
chitosan 
 residuals 
- - 
Induced  
vascularization, 
prolonged the 
 half-life of growth 
factors 
Retain of growth  
factor's biological 
activity 
Methacrylated hyaluronic acid  
MeHA  
(Tous et al. 2011) 
30 min - Stable - 
Adjustable 
with  
crosslinking 
Increased vessel 
formation,  
myocardial  
thickness better 
than HeMAHA 
Inflammation 
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Hydrogel 
Injection after 
myocardial 
infarction (MI) 
Gelation mech-
anism and time 
Stability 
Cells used in 
compatibility 
testing 
Mechanical  
properties 
Advantages Disadvantages 
Methacrylated 
hyaluronic acid 
 HeMA-HA  
(Tous et al. 
2011) 
30 min 
 
 
- 
 
Hydrolytic bulk 
 degradation, 3-
10 weeks 
- 
 
Increased meth-
acrylation led to 
increased com-
pressive moduli 
Increased vessel  
formation 
Inflammation 
Myocardial  
matrix from por-
cine  
(Singelyn et al. 
2009) 
MI not induced 
Self-assembling 
in situ 
- 
For viability 
neonatal rat  
cardiomyocytes; 
for migration 
human coronary 
artery endothelial 
cells and rat  
aortic 
smooth muscle 
cells 
Pore size 30 μm, 
fibers 40-100 nm 
Promotes vascu-
lar cell migration 
in vitro and  
infiltration in 
vivo in 1-2 weeks 
Xenograft issues,  
3D properties  
partially lost,  
difficult to pre-
pare 
Synthetic 
Dextran-PCL-
HEMA/PNIPAM 
(Wang, T. 2009) 
Four days 
Thermal, 
 in situ 
30 days  
 in vivo 
- - 
Thicken the scar, 
improves ven-
tricular function, 
prevent left ven-
tricle remodeling 
after 30 days 
Effects on dias-
tolic function and 
 arrhythmia 
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Hydrogel 
Injection 
after 
myocar-
dial 
infarc-
tion (MI) 
Gelation 
mecha-
nism and 
time 
Stability 
Cells used in 
compatibility 
testing 
Mechani-
cal  
properties 
Advantages Disadvantages 
 
Poly (NIPAM-co-AA-co-
HEMAPTMC) (86/4/10) 
 (Fujimoto et al. 2009) 
 
14 days 
 
Thermal, 
time  
controlled 
through 
acrylic acid 
content 
 
Hydrolytic 
cleavage in 
five months in 
vitro 
 
Rat vascular 
smooth muscle 
cells 
 
Elastic, easy 
to handle 
 
Contractile  
function improved, 
ventricular dilation  
 
Extra cells found in 
left ventricle wall; 
changes in left  
ventricle architecture 
and function in 
long-term 
NIPAM+ AA+ NAS+ HEMA-
PTMC 
(Li et al. 2012) 
- 
6-7 s in 37° 
C 
92 ± 2% of 
weight re-
maining after 
a 14 days 
Mesenchymal 
stem cells 
Best 
cardiomyo-
cyte 
differentia-
tion with 65 
kPa;  
flexibility 
- - 
Vinyl sulfone modified 
polyethylene glycol 
(Dobner et al. 2009) 
 
Two 
minutes 
 
Redox 
initiation; 
few minutes 
in 37° C 
Non-
degradable 
- 
 
Stiffness 
mimicking 
that of 
myocardial 
tissue’s 
 
Increased scar 
thickness and 
decreased heart 
dimensions 
 
Inflammation, 
thickened myocardial 
wall, fractional 
shortening not 
improved 
Polyethylene glycol+ hyaluronic 
acid 
(Yoon et al. 2009) 
14 days; 
ten  
minutes 
- 
Four weeks 
(hydrolysis) 
- - 
Easy to apply; 
myocardial 
recovery 
Reliability of the 
study: degree of MI 
not severe 
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Hydrogel 
Injection 
after 
myocar-
dial 
infarction 
(MI) 
Gelation 
mechanism 
and time 
Stability 
Cells used in 
compatibility 
testing 
Mechanical  
properties 
Advantages Disadvantages 
Fibrin glue (2% fibrinogen) and 
mesenchymal stem cells  
(Martens et al. 2009) 
Immediate 
In situ; 6–8 
min for 
<15% 
 fibrinogen  
- 
Human 
 mesenchymal 
stem cells 
Pore size 
20-40 μm  
Enhanced cell 
retention, 
 prevented cell 
 redistribution to 
other organs 
Viscosity problems 
Matrigel 
 (Ou et al. 2011) 
Immediate - - - - 
Enhanced systolic 
and diastolic 
 properties of the 
infracted tissue, 
promoted  
neovascularization 
No reduction in the 
size of MI 
Matrigel+ mouse embryonic stem 
cells 
 (Kofidis et al. 2004) 
Immediate 
Solid after 
few minutes 
from mixing 
- - - 
Prevented  
ventricular wall 
thinning, cells 
viable in Matrigel, 
cardiac function 
better than in peer 
group 
Possibility of tumor 
formation 
 
 
 
 
 
  
APPENDIX 1. HYDROGELS STUDIED FOR TREATMENT OF MYOCARDIAL INFARCTION 
Hydrogel 
Injection 
after 
myocardial 
infarction 
(MI) 
Gelation mech-
anism and time 
Stability 
Cells used in 
compatibility 
testing 
Mechanical  
properties 
Advantages Disadvantages 
Silanized  
hydroxypropyl  
methylcellulose 
hydrogel with cells  
(Mathieu et al. 2012) 
Immediate 
Self-setting,  
30 minutes 
Eight 
weeks in 
bone 
Mesenchymal 
stem cells  
 
Elastic modu-
lus 0,3 kPa  
 
Limited the  
extent of 
transmural MI, preserved 
endocardial myocytes 
and reduced 
metaplasia, can be steam 
sterilized 
 
Only short- and 
mid-term  
recovery of  
ventricular  
function; 
 deterioration after 
four weeks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
APPENDIX 2. GEL TEST RESULTS 
Symbol Key 
A Liquid 
B Small traces of gel in liquid 
C Almost completely gelled 
D Completely gelled 
 
Gel type 
 
 
PNIPAM-
HA 
 Component A Component B 
Ratio of com-
ponents (A:B) 
Polymer  
concentration 
(%) 
Gelation 
temperature 
(
o 
C) 
Gelation time points (min) 
 
mg/cm
3
 cm
3
  mg/cm
3
 cm
3
 0 1 5 60 
1 KOPO-1 15 0.1 HA-1 15 0.1 1:1 1.5 r.t. B B B C 
2 KOPO-1 20 0.1 HA-1 10 0.1 2:1 1.5 r.t. B B B B 
3 KOPO-1 25 0.1 HA-1 5 0.1 5:1 1.5 r.t. B B B B 
4 KOPO-1 15 0.1 HA-2 15 0.1 1:1 1.5 r.t. B B B B 
5 KOPO-1 20 0.1 HA-2 10 0.1 2:1 1.5 r.t. B B B B 
6 KOPO-1 25 0.1 HA-2 5 0.1 5:1 1.5 r.t. B B B B 
7 KOPO-1 15 0.1 HA-1 15 0.1 1:1 1.8 37 A A A A 
8 KOPO-1 20 0.3 HA-1 10 0.3 2:1 1.8 37 A B B A 
9 KOPO-1 25 0.3 HA-1 5 0.3 5:1 1.8 37 A B B B 
10 KOPO-1 15 0.3 HA-2 15 0.3 1:1 1.8 37 A A B B 
11 KOPO-1 20 0.3 HA-2 10 0.3 2:1 1.8 37 A B B B 
12 KOPO-1 15 0.3 HA-1 15 0.3 1:1 1.8 37 A B B B 
13 KOPO-1 25 0.6 - - - - 1.5 37 A A A A 
14 KOPO-1 60 0.2 HA-1 60 0.2 1:1 4.8 r.t. B B B B 
15 KOPO-1 60 0.2 HA-2 60 0.2 1:1 4.8 r.t. B B B B 
16 KOPO-1 60 0.2 HA-1 60 0.2 1:1 4.8 4 B B B B 
17 KOPO-1 60 0.2 HA-2 60 0.2 1:1 4.8 4 B B B B 
 
  
APPENDIX 2. GEL TEST RESULTS 
Symbol Key 
A Liquid 
B Small traces of gel in liquid 
C Almost completely gelled 
D Completely gelled 
Gel type 
 
 
PNIPAM-
HA or 
PNIPAM- 
AL 
 Component A Component B 
Ratio of components 
(A:B) 
Polymer 
concentration 
(%) 
Gelation 
temperature 
(
o 
C) 
Gelation time points (min) 
 
mg/c
m
3
 
cm
3
  mg/cm
3
 cm
3
 0 1 5 60 
1 KOPO-2 15 0.2 AL-1 15 0.2 1:1 0.75 r.t. A B B B 
2 KOPO-2 20 0.2 AL-1 10 0.2 2:1 0.75 r.t. A A B B 
3 KOPO-2 25 0.2 AL-1 25 0.2 1:1 1.0 r.t. A A B B 
4 KOPO-2 50 0.2 AL-1 10 0.2 5:1 2.4 r.t. A B B B 
5 KOPO-2 60 0.2 AL-1 60 0.2 1:1 4.8 4 B B B B 
6 KOPO-2 60 0.2 AL-1 30 0.2 2:1 1.8 4 B B B B 
7 KOPO-2 60 0.2 AL-2 60 0.2 1:1 4.8 4 B B B C 
8 KOPO-2 60 0.2 AL-2 30 0.2 2:1 1.8 4 B B B B 
9 KOPO-2 60 0.2 AL-1 60 0.2 1:1 4.8 r.t. B B B B 
10 KOPO-2 60 0.2 AL-2 60 0.2 1:1 4.8 r.t. B B B B 
11 KOPO-2 15 0.2 HA-2 15 0.2 1:1 1.2 r.t. A A A A 
12 KOPO-2 20 0.2 HA-2 10 0.2 2:1 1.2 r.t. B B B B 
13 KOPO-2 25 0.2 HA-2 20 0.2 5:4 1.8 r.t. B B B A 
14 KOPO-2 50 0.2 - - - - 1.0 r.t. B B B B 
15 KOPO-2 60 0.2 AL-1 60 0.2 1:1 4.8 4 B B B B 
16 KOPO-2 60 0.2 AL-2 60 0.2 1:1 4.8 4 B B B C 
17 KOPO-2 60 0.2 AL-1 60 0.2 1:1 4.8 r.t. B B B B 
18 KOPO-2 60 0.2 AL-2 60 0.2 1:1 4.8 r.t. B B B B 
  
APPENDIX 3: 
1
H-NMR SPECTRA OF ALGINATE 
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1
H NMR spectrum of alginate. 
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1
H NMR spectrum of oxidized alginate AL-1. 
 
 
  
APPENDIX 4: 
1
H-NMR SPECTRA OF ALGINATE AND 
HYALURONIC ACID 
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1
H NMR spectrum of oxidized alginate AL-2. 
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1
H NMR spectrum of hyaluronic acid. 
 
  
APPENDIX 5: 
1
H-NMR SPECTRA OF HYALURONIC  
ACID 
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1
H NMR spectrum of oxidized hyaluronic acid HA-1. 
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1
H NMR spectrum of oxidized hyaluronic acid HA-2. 
  
APPENDIX 6: FTIR SPECTRA OF ALGINATE AND  
HYALURONIC ACID 
 
FTIR spectra of alginate and its derivatives. 
 
FTIR spectra of hyaluronic acid and its derivatives. 
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